Stock Information
Puma Biotechnology Inc (PBYI)
Ticker Symbol: PBYI
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $486.09 mil
Piotroski score: 5
PE Ratio: 19.65
EPS (TTM): 0.48
Revenue (TTM): $4.47 M
Dividend Yield: N/A
ROE: 20.37%
Latest News
-
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
Fri, Sep 18, 2026 2:48 PM
-
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
Thu, Sep 17, 2026 8:07 PM
-
Puma Biotechnology Initiates ALISertib In CAncer Phase II Trial Of Alisertib In Combination With Paclitaxel For Treatment Of Patients With Advanced Small Cell Lung Cancer
Thu, Sep 17, 2026 4:10 PM
Key Financials
Financial data not available
